Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

January 20, 2024

Study Completion Date

March 20, 2024

Conditions
Myeloproliferative NeoplasmPolycythemia VeraEssential ThrombocythemiaPrimary MyelofibrosisPrefibrotic/Early Primary Myelofibrosis
Interventions
DIAGNOSTIC_TEST

ULTRASOUND EXAM AND MRI SCAN

Within two weeks from the US, each patient underwent an MRI of the upper abdomen to evaluate the splenic volume. MRI examinations were performed using a 3T Biograph mMR scanner (Siemens Healthcare, Erlangen, Germany) with 4-channel flex phased-array body coil. Routine clinical abdominal MRI acquisition includes coronal T2W Half-Fourier Acquisition Single-shot Turbo spin Echo imaging (HASTE), axial T1 Dual-echo FSE, axial T2 TSE Fat Sat, and an axial diffusion-weighted imaging (DWI).

Trial Locations (1)

80131

Federico II University, Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT06371573 - Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms | Biotech Hunter | Biotech Hunter